scispace - formally typeset
R

Richard W. Titball

Researcher at University of Exeter

Publications -  416
Citations -  23987

Richard W. Titball is an academic researcher from University of Exeter. The author has contributed to research in topics: Burkholderia pseudomallei & Clostridium perfringens. The author has an hindex of 79, co-authored 410 publications receiving 22484 citations. Previous affiliations of Richard W. Titball include Imperial College London & United States Army Medical Research Institute of Infectious Diseases.

Papers
More filters
Journal ArticleDOI

A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei

Anthony E. Gregory, +7 more
- 01 Feb 2015 - 
TL;DR: In this paper, gold nanoparticles (AuNPs) were used with a glycoconjugate vaccine against B. mallei in the murine model of infection.
Journal ArticleDOI

Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence

Joanne Elizabeth Thwaite, +3 more
- 01 Jul 2006 - 
TL;DR: Findings suggest that alongside the classical plasmid-based virulence determinants, extracellular metalloproteases of B. anthracis may play a role in survival in the host.
Journal ArticleDOI

A rapid, highly sensitive method for the detection of Francisella tularensis in clinical samples using the polymerase chain reaction

Mark Fulop, +2 more
- 01 Apr 1996 - 
TL;DR: A highly sensitive method based on a nested polymerase chain reaction (PCR) for the FopA gene that has significant advantages over traditional methods for diagnosing F. tularensis infection in terms of speed, ease of use, reproducibility, and safety.
Journal ArticleDOI

Development of vaccines against burkholderia pseudomallei.

Natasha Patel, +5 more
- 27 Sep 2011 - 
TL;DR: This review considers the multiple elements of melioidosis vaccine research including the immune responses required for protective immunity, the animal models available for preclinical testing of potential candidates, the different experimental vaccine strategies which are being pursued, and the obstacles and opportunities for eventual registration of a licensed vaccine in humans.
Journal ArticleDOI

The ABC Transporter Protein OppA Provides Protection against Experimental Yersinia pestis Infection

Mikio Tanabe, +9 more
- 01 Jun 2006 - 
TL;DR: The potential for ATP-binding cassette (ABC) transporter proteins to be exploited as novel vaccines against plague was evaluated and protection appeared to correlate with the level of immunoglobulin G antibody to OppA.